Andrew Galler
Stock Analyst at Morgan Stanley
(0.51)
# 3,899
Out of 4,761 analysts
28
Total ratings
27.78%
Success rate
-15.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrew Galler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMCR Immunocore Holdings | Downgrades: Equal-Weight | $74 → $35 | $29.92 | +16.98% | 12 | Dec 13, 2024 | |
| FOLD Amicus Therapeutics | Maintains: Equal-Weight | $14 → $15 | $9.19 | +63.22% | 5 | Nov 9, 2023 | |
| SLN Silence Therapeutics | Initiates: Equal-Weight | $18 | $4.79 | +275.78% | 1 | Dec 9, 2022 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Equal-Weight | $41 → $37 | $19.90 | +85.93% | 2 | Nov 29, 2022 | |
| IONS Ionis Pharmaceuticals | Maintains: Overweight | $57 → $56 | $32.32 | +73.27% | 2 | Nov 10, 2022 | |
| VIR Vir Biotechnology | Maintains: Underweight | $15 → $18 | $9.57 | +88.09% | 2 | Nov 4, 2022 | |
| PTCT PTC Therapeutics | Initiates: Equal-Weight | $54 | $50.69 | +6.53% | 1 | Sep 9, 2022 | |
| HALO Halozyme Therapeutics | Initiates: Overweight | $50 | $57.75 | -13.42% | 1 | Sep 9, 2022 | |
| ADCT ADC Therapeutics | Initiates: Outperform | $44 | $1.63 | +2,599.39% | 1 | Nov 9, 2021 | |
| MRNA Moderna | Initiates: Outperform | $304 | $35.53 | +755.61% | 1 | Nov 9, 2021 |
Immunocore Holdings
Dec 13, 2024
Downgrades: Equal-Weight
Price Target: $74 → $35
Current: $29.92
Upside: +16.98%
Amicus Therapeutics
Nov 9, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $9.19
Upside: +63.22%
Silence Therapeutics
Dec 9, 2022
Initiates: Equal-Weight
Price Target: $18
Current: $4.79
Upside: +275.78%
Arrowhead Pharmaceuticals
Nov 29, 2022
Maintains: Equal-Weight
Price Target: $41 → $37
Current: $19.90
Upside: +85.93%
Ionis Pharmaceuticals
Nov 10, 2022
Maintains: Overweight
Price Target: $57 → $56
Current: $32.32
Upside: +73.27%
Vir Biotechnology
Nov 4, 2022
Maintains: Underweight
Price Target: $15 → $18
Current: $9.57
Upside: +88.09%
PTC Therapeutics
Sep 9, 2022
Initiates: Equal-Weight
Price Target: $54
Current: $50.69
Upside: +6.53%
Halozyme Therapeutics
Sep 9, 2022
Initiates: Overweight
Price Target: $50
Current: $57.75
Upside: -13.42%
ADC Therapeutics
Nov 9, 2021
Initiates: Outperform
Price Target: $44
Current: $1.63
Upside: +2,599.39%
Moderna
Nov 9, 2021
Initiates: Outperform
Price Target: $304
Current: $35.53
Upside: +755.61%